Contact us
Announcements, milestones, and press coverage as we work to transform the fertility space through organoid medicine and AI. For interviews, data, or imagery, our team is one email away.
For interviews, quotes, or background on Simbryo's organoid medicine platform, reach out to our team directly.
[email protected]Download our logo files, color palette, and usage guidelines for editorial use.
Download brand assets ↓Simbryo Technologies is a commercial-stage biotech company accelerating paths to pregnancy via organoid medicine and AI. Working with top research institutions and fertility clinics, Simbryo develops personalized diagnostic platforms that predict and optimize endometrial fertility, giving patients and physicians actionable insights to increase success rates and providing a powerful in-vitro test bed for novel fertility treatments.